Additionally, they explored second‐order interactions, particularly between a 30 g dose of metformin and the SLC47A2 rs12943590 genotype, which had a notable impact on fasting insulin levels in patients with T2DM. The gene discussed is SLC47A2; the disease is type 2 diabetes mellitus.